Veracyte, Inc. (VCYT)
NASDAQ · Services · Services-medical laboratories
$45.43−$3.11 (−6.41%) on the dayAs of the close; data may be delayed.
VCYT price, last 12 months
Key stats
- Previous close
- $48.54
- Open
- $48.62
- Day range
- $45.36 – $49.10
- 52-week range
- $29.46 – $60.91
- Volume
- 1.3M
- Avg volume (20 days)
- 1.4M
- Market cap
- $3.7B
Performance
1W+14.2%
1M+2.6%
3M−24.9%
6M+38.5%
YTD+7.9%
1Y+39.0%
vs S&P 500, 1Y+22.2 pts
Technicals and fundamentals
About Veracyte, Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
- Sector
- Services
- Industry
- Services-medical laboratories
- Listed on
- NASDAQ
- Market cap
- $3.7B